Poster Presentation at the 19th Vaccine Congress Featuring Collaborative Research Using MylcMAT
We are pleased to announce that collaborative research utilizing our proprietary technology, MylcMAT, will be presented at the 19th Vaccine Congress, held in Kyoto from September 7 to 10, 2025.
This presentation is based on joint research conducted with the National Institute of Health Crisis Management, which will be responsible for the poster presentation. From our company, Sato and Tokuda of the R&D Department have contributed as co-authors.
We invite all interested attendees to visit the poster and learn more about our findings
– Presentation Details –
Format: Poster Presentation
Poster Number / Title: P3.101 / Safety and vaccine efficacy of outer membrane vesicles of three isogenic lipid A mutants of probiotic Escherichia coli
Presentation Date: September 9, 2025
Venue: Kyoto International Conference Center
